InVivo Therapeutics (NSDQ:NVIV) today released 12-month results from the closed Inspire study of its neuro-spinal scaffold, touting improvements in ASIA impairment scales.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,